Skip to main content
. 2010 Oct 13;17(12):1985–1990. doi: 10.1128/CVI.00294-10

FIG. 4.

FIG. 4.

The ESAT-6-, CFP-10-, and PPD-specific SFCs of ELISPOT assay with ATB patients and HC. Ex vivo ELISPOT assay was performed on 46 ATB patients receiving anti-TB treatment equal to or shorter than 1 month and 50 healthy individuals. The short transverse line represents median of SFCs in different subgroups.